Chevron vs Marathon Petroleum
CVX and MPC side by side, both in petroleum refining. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CVX and MPC compare
Chevron is the larger company, worth 3.7 times as much as Marathon Petroleum ($434B against $116B).
On earnings, Marathon Petroleum is cheaper: it trades at 14.3× trailing earnings, against 16.1× for Chevron.
Chevron grew revenue faster over the last twelve months (20.0% versus 15.0% for Marathon Petroleum).
Chevron keeps more of each dollar of sales as profit, with a net margin of 11.6% compared with 5.6% at Marathon Petroleum.
Both pay dividends: Chevron yields 3.2% and Marathon Petroleum 0.96%.
Chevron scores higher on the StockData Score (14 against 12 for Marathon Petroleum), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CVX | MPC |
|---|---|---|
| Size and price | ||
| Market cap | $434B | $116B |
| Share price | $219.89 | $414.65 |
| Change, 1 year | 43.4% | 111% |
| Change, 5 years | 96.5% | 588% |
| Beta (5Y) | 0.40 | 0.57 |
| Employees | 4,645 | 19K |
| StockData Score | ||
| Total score | 14 (better) | 12 |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 (better) | 1 |
| Performance score | 2 | 3 (better) |
| Health score | 5 (better) | 4 |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 16.1× | 14.3× (better) |
| P/S | 1.9× | 0.8× (better) |
| P/B | 2.2× (better) | 6.1× |
| EV/EBITDA | 6.6× (better) | 8.5× |
| P/FCF | 12.8× | 9.0× (better) |
| FCF yield | 7.8% | 11.1% (better) |
| Fair value | $197.71 | $339.78 |
| Margin of safety | −11.2% (better) | −22.0% |
| Growth | ||
| Revenue growth (TTM) | 20.0% (better) | 15.0% |
| Revenue growth, 5Y average | 14.8% (better) | 13.7% |
| Net income growth (TTM) | 111% | 301% (better) |
| EPS growth (TTM) | 92.8% | 331% (better) |
| Profitability | ||
| Gross margin | 45.7% (better) | 12.5% |
| Operating margin | – | 9.2% |
| Net margin | 11.6% (better) | 5.6% |
| FCF margin | 14.6% (better) | 8.4% |
| Return on equity | 14.0% | 47.9% (better) |
| Return on invested capital | – | 26.0% |
| Financial health | ||
| Debt / equity | 0.00 (better) | 1.72 |
| Net debt / EBITDA | −0.21 | 1.44 (better) |
| Interest coverage | – | 8.7× |
| Current ratio | 1.34 (better) | 1.25 |
| Altman Z-score | 3.62 | 3.89 (better) |
| Piotroski F-score | 5 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 3.2% (better) | 0.96% |
| Payout ratio | 51.6% | 13.6% |
| Years of dividend growth | 6 (better) | 4 |
| Dividend growth, 5Y average | 5.8% | 10.0% (better) |
| Buyback yield | 2.5% | 4.2% (better) |
| Shareholder yield | 5.8% (better) | 5.2% |
| Ownership | ||
| Held by institutions | 74.3% | 78.0% |
| Held by insiders | 0.34% | 0.30% |
| Insider net buying, 12 months | −$592M | −$13.9M (better) |
| Superinvestors holding | 4 (better) | 1 |
| Short interest, % of float | 1.3% | 2.3% |
Go deeper
- CVX stock overview
- CVX income statement
- CVX valuation and score
- MPC stock overview
- MPC income statement
- MPC valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.